|
Gliotaz |
 |
"For improved quality of life in Patients with Glioblastoma & Refractory Ana plastic Astrocytoma"
Most trusted Imidazotetrazine derivative
- Concomitantly with Radiotherapy & as maintenance therapy.
- Improves progression free survival in Glioblastoma Multiforme
- High response rate in newly diagnosed Anaplastic Oligodendrogliomas.
- Patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.
| BENIFITS |
| Demonstrable response rates |
| Acceptable tolerability profile |
| Convenient oral daily dose, no dietary restrictions. |
| COMPOSITION |
| Gliotaz 20mg Temozolomide (Strip of 5 Caps) |
| Gliotaz 100mg Temozolomide (5 monocartons of one capsules each in a big carton) |
| Gliotaz 250mg Temozolomide (5 monocartons of one capsules each in a big carton) |
|
|
|
